Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 2 $ 129,725 $ (72,258) $ 57,469
Balance (in Shares) at Dec. 31, 2020 23,264,637      
Exercise of stock options [1] 130   130
Exercise of stock options (in Shares) 84,239      
Exercise of warrant [2]
Exercise of warrant (in Shares) [2] 362,383      
Issuance of Common Stock under Open Market Sales Agreement [3] [1] 5,188 5,188
Issuance of Common Stock under Open Market Sales Agreement (in Shares) [3] 743,964      
Issuance of Common Stock under Securities Purchase Agreement (“SPA”), net of $1,235 issuance costs [3] [1] 13,765 13,765
Issuance of Common Stock under Securities Purchase Agreement (“SPA”), net of $1,235 issuance costs (in Shares) [3] 3,750,000      
Issuance of Common Stock under Stock Purchase Agreement with Maruho, net of $52 issuance costs [3] [1] 972 972
Issuance of Common Stock under Stock Purchase Agreement with Maruho, net of $52 issuance costs (in Shares) [3] 375,000      
Issuance of Common Stock under Securities Purchase Agreement with CF Foundation [3] [1] 3,000 3,000
Issuance of Common Stock under Securities Purchase Agreement with CF Foundation (in Shares) [3] 1,167,315      
Stock-based compensation expenses 3,237 3,237
Net loss (36,226) (36,226)
Balance at Dec. 31, 2021 $ 2 156,017 (108,484) 47,535
Balance (in Shares) at Dec. 31, 2021 29,747,538      
Issuance of Common Stock under Open Market Sales Agreement [3] [1] 273 273
Issuance of Common Stock under Open Market Sales Agreement (in Shares) [3] 229,044      
Stock-based compensation expenses   1,529 1,529
Proceeds on account of shares   19   19
Net loss (28,317) (28,317)
Balance at Dec. 31, 2022 $ 2 $ 157,838 $ (136,801) $ 21,039
Balance (in Shares) at Dec. 31, 2022 29,976,582      
[1] Less than $1.
[2] See Note 13B(1).
[3] See Note 13A.